Hims & Hers Completes Eucalyptus Acquisition, Bolstering Consumer Health Platform
Reported by Dow Jones Newswires
Sentiment
Positive
Importance
8
Price
$27.945
Mkt Cap
$6.193B
52W Low
$13.74
52W High
$70.43
Market data snapshot near publication time
Summary
Hims & Hers has completed its acquisition of Eucalyptus, a strategic move that the company states will advance its position as the world's largest consumer health platform. This acquisition strengthens Hims & Hers' market presence and expands its offerings. The company has been actively pursuing growth initiatives, including recent partnerships for GLP-1 weight-loss drugs and a significant convertible note offering.
At the time of this announcement, HIMS was trading at $27.95 on NYSE in the Technology sector, with a market capitalization of approximately $6.2B. The 52-week trading range was $13.74 to $70.43. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.
Price Chart
HIMS - Latest Insights
HIMS
Jun 02, 2026, 5:00 AM EDT
HIMS
May 26, 2026, 4:48 PM EDT
HIMS
May 21, 2026, 5:05 PM EDT
HIMS
May 19, 2026, 8:17 AM EDT
HIMS
May 19, 2026, 12:08 AM EDT
HIMS
May 18, 2026, 7:17 AM EDT
HIMS
May 12, 2026, 7:28 AM EDT
HIMS
May 11, 2026, 4:15 PM EDT
HIMS
May 11, 2026, 4:08 PM EDT
HIMS
May 11, 2026, 4:06 PM EDT